73 related articles for article (PubMed ID: 9218060)
1. [Zotepin--its value and potentials for further development].
Nervenarzt; 1994 Jul; 65(7 Suppl):1-8. PubMed ID: 9218060
[No Abstract] [Full Text] [Related]
2. Treatment of clozapine-associated tardive dyskinesia.
Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
[No Abstract] [Full Text] [Related]
3. Schizophrenia.
Lawrie S; McIntosh A; Nadeem Z
Clin Evid; 2005 Dec; (14):1306-30. PubMed ID: 16620456
[No Abstract] [Full Text] [Related]
4. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
Fleischhacker WW; Barnas C; Stuppäck CH; Unterweger B; Miller C; Hinterhuber H
Psychopharmacol Bull; 1989; 25(1):97-100. PubMed ID: 2570438
[No Abstract] [Full Text] [Related]
5. Schizophrenia.
Nadeem Z; McIntosh A; Lawrie S
Clin Evid; 2003 Dec; (10):1208-37. PubMed ID: 15555143
[No Abstract] [Full Text] [Related]
6. Clinical predictors of schizophrenic patient response to neuroleptics.
Korínková V
Act Nerv Super (Praha); 1989 Jun; 31(2):115-6. PubMed ID: 2572131
[No Abstract] [Full Text] [Related]
7. Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia.
Ellenbroek BA; Liégeois JF; Bruhwyler J; Cools AR
J Pharmacol Exp Ther; 2001 Jul; 298(1):386-91. PubMed ID: 11408566
[TBL] [Abstract][Full Text] [Related]
8. Exacerbation of tics secondary to clozapine therapy.
Bastiampillai T; Dhillon R; Mohindra R
Aust N Z J Psychiatry; 2008 Dec; 42(12):1068-70. PubMed ID: 19034993
[No Abstract] [Full Text] [Related]
9. Effects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophrenia.
Levin ED; Christopher NC
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):223-9. PubMed ID: 16356617
[TBL] [Abstract][Full Text] [Related]
10. Clozapine compared with haloperidol for refractory schizophrenia.
Birkett DP
N Engl J Med; 1998 Jan; 338(4):267-8. PubMed ID: 9441246
[No Abstract] [Full Text] [Related]
11. [Social cognition and atypical antipsychotic agents in the treatment of persons with schizophrenia: preliminary data from a naturalistic study].
Mazza M; Tozzini C; Giosué P; De Risio A; Palmucci M; Roncone R; Casacchia M
Clin Ter; 2003; 154(2):79-83. PubMed ID: 12856365
[TBL] [Abstract][Full Text] [Related]
12. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotic effects of quetiapine fumarate in animal models.
Guan HJ; Dai J; Zhu XZ
Acta Pharmacol Sin; 2000 Mar; 21(3):205-10. PubMed ID: 11324416
[TBL] [Abstract][Full Text] [Related]
14. Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.
Oh PI; Iskedjian M; Addis A; Lanctôt K; Einarson TR
Can J Clin Pharmacol; 2001; 8(4):199-206. PubMed ID: 11743592
[TBL] [Abstract][Full Text] [Related]
15. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
[TBL] [Abstract][Full Text] [Related]
16. Clozapine maintenance therapy in schizophrenia.
Gaszner P; Makkos Z
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
[TBL] [Abstract][Full Text] [Related]
17. Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs.
Sun T; Hu G; Li M
Eur J Pharmacol; 2009 Jan; 602(2-3):334-42. PubMed ID: 19059234
[TBL] [Abstract][Full Text] [Related]
18. A putative animal model of the "prodromal" state of schizophrenia.
Tenn CC; Fletcher PJ; Kapur S
Biol Psychiatry; 2005 Mar; 57(6):586-93. PubMed ID: 15780845
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine.
Gama CS; Salvador M; Andreazza AC; Kapczinski F; Silva Belmonte-de-Abreu P
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):512-5. PubMed ID: 16426720
[TBL] [Abstract][Full Text] [Related]
20. Further clinical experience with oxyprothepin-decanoate.
Kalvach Z; Hálková E; Bastecký J
Act Nerv Super (Praha); 1981 Dec; 23(4):271-2. PubMed ID: 6121440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
